Finding 12114 (2022-001)

-
Requirement
A
Questioned Costs
-
Year
2022
Accepted
2022-12-26
Audit: 16158
Auditor: Rsm US LLP

AI Summary

  • Core Issue: Lab expenses reported for Period 2 were overstated by about $1,059,000 due to double counting from two locations.
  • Impacted Requirements: Compliance with federal reporting criteria under CFR Part 200.303(a) and HRSA guidelines for accurate fund usage reporting.
  • Recommended Follow-Up: Management should enhance internal control processes to prevent future reporting errors.

Finding Text

Finding 2022-001? Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Reporting Federal program: Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution, ALN 93.498 Criteria: 2. CFR Part 200.303(a) states that the auditee must establish and maintain effective internal control over the federal awards that provides reasonable assurance that the auditee is managing the federal award in compliance with the federal statutes, regulations, and terms and conditions of the federal award. Specific criteria established by the Health Resources and Services Administration (HRSA) reporting guidance, establishes that providers who accept PRF payments agree to the Terms and Conditions of the Program, which include a requirement for providers to report on the use of funds. Providers who receive one or more payments totaling greater than $10,000 in the aggregate during a payment received period must report on use of funds in each applicable reporting period. Condition: Certain amounts reported as lab expenses for Period 2 were overstated by approximately $1,059,000. The Corporation double counted lab expenses from two locations. Cause: Upon review by management subsequent to Period 2 submission to the Reporting Portal, management identified an overstatement of certain lab expenses from two lab locations that were inadvertently included twice in the total eligible expenses within the Reporting Portal. Effect: Certain lab expenses reported for Period 2 in the Reporting Portal were overstated by approximately $1,059,000. Questioned costs: No Context: Lab expenses of approximately $1,059,000 out of total eligible expenses reported to the Reporting Portal for Period 2 of $10,400,983 were overstated. The error was isolated to the expenses from two outside labs reported in Period 2. Repeat finding? No Recommendation: We recommend management review and strengthen its internal control review process over reporting. Views of responsible officials of the auditee: The Corporation?s management agrees with the finding and the auditor?s recommendation.

Corrective Action Plan

Corrective Action Plan For: SwedishAmerican Health System Finding number: 2022-001 Description of the finding: Amounts reported as eligible expenses in Reporting Period 2 were overstated by approximately $1,059,100. Corrective actions taken or planned: Lab expenses were erroneously duplicated due to using two sources for COVD-19 lab expenses ? 1) lab expenses internally charged to certain departments, and 2) a summary of lab expenses for all departments. This was discovered in April 2022, after Reporting Period 2 had closed on March 31, 2022. The reporting portal does not allow edits to a prior closed period; therefore, we assessed all received PRF funds against all uses of funds. Reporting Period 1 and 2 we only used expenses; however, we had lost revenue of approximately ($26,783,301) when comparing actual net revenues from April 1, 2020 to June, 30 2020, to the same period April 1, 2019 to June 30, 2019. When subtracting overstated lab expenses of $1,059,100 from Reporting Period 2, this leaves lost revenues of approximately ($25,724,223) to use in in future reporting periods. Reporting Period 3 and Reporting Period 4 we received funds of approximately $17,354,104 which is less than the remaining lost revenue of approximately ($25,724,223). Reporting Period 3 and Reporting Period 4 will only use lost revenues to justify the funds received. If we could correct reporting period 2 we would claim $1,059,100 against lost revenue and reduce the duplicated expense. However, if we receive funds for reporting periods after Reporting Period 4, we will deduct the excess expenses reported from lost revenues remaining to be claimed. Anticipated completion date: 4/18/2022 Person responsible for Corrective Action Plan: Patricia DeWane, CFO and Treasurer, (779) 696-4009 pdewane@uwhealth.org SwedishAmerican Health System, SwedishAmerican Hospital, DBA UW Health

Categories

Reporting Internal Control / Segregation of Duties

Other Findings in this Audit

Programs in Audit

ALN Program Name Expenditures
93.498 Provider Relief Fund $24.06M
93.788 Opioid Str $456,915
93.461 Covid-19 Testing for the Uninsured $297,378
93.575 Child Care and Development Block Grant $238,140